Drawing based on the label description. No photo yet.
RDY 617 pill
Pill with imprint RDY 617 is blue, round, 6 mm and has been identified as Eszopiclone 3 mg. It is supplied by A-S Medication Solutions.
Controlled substance: Schedule IV
Eszopiclone 3 mg
- Imprint
- RDY 617
- Strength
- 3 mg
- Color
- Blue
- Shape
- Round
- Size
- 6 mm
- Score
- No score line
- Form
- Tablet, coated
- Manufacturer
- A-S Medication Solutions
- NDC
- 50090-5084, 55111-617, 50090-5084-0, 55111-617-30, 55111-617-90, 55111-617-01, 55111-617-05, 55111-617-79, 55111-617-09, 80425-0067, 80425-0067-1
Is this your pill? Check every detail
- The imprint reads exactly RDY 617, on the same sides.
- It is blue, round, 6 mm.
- The score line, coating and any logo match the photo.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Eszopiclone
Inactive: Croscarmellose Sodium, Hypromellose, Unspecified, Lactose Monohydrate, Magnesium Stearate, Polyethylene Glycol 400, Titanium Dioxide, Triacetin, Microcrystalline Cellulose, Fd&c Blue No. 2
Also distributed by
Dr. Reddy's Laboratories Limited, Advanced Rx of Tennessee, LLC
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
APO MID 10
Midodrine Hydrochloride 10 mg
Blue, round, 7 mm
-
K 9
Oxycodone Hydrochloride 30 mg
Blue, round, 6 mm
Schedule II
-
L24
Levothyroxine Sodium 0.15 mg
Blue, round, 6 mm
-
020
Nadolol 20 mg
Blue, round, 7 mm
-
I 157
Propranolol Hydrochloride 20 mg
Blue, round, 6 mm
-
ABG 15
Morphine Sulfate 15 mg
Blue, round, 7 mm
Schedule II
Other Eszopiclone pills
- 382 G Eszopiclone 1 mg Blue, round, 6 mm Schedule IV
- 382 G Eszopiclone 3 mg Blue, round, 6 mm Schedule IV
- 383 G Eszopiclone 2 mg White, round, 6 mm Schedule IV
- 384 G Eszopiclone 3 mg Blue, round, 6 mm Schedule IV
- 54 396 Eszopiclone 3 mg White, round, 9 mm Schedule IV
- 93 E7 Eszopiclone 1 mg Blue, round, 6 mm Schedule IV
- 93 E8 Eszopiclone 2 mg White, round, 6 mm Schedule IV
- 93 E9 Eszopiclone 3 mg Blue, round, 6 mm Schedule IV